Gabriele D.
- Country
- Italy
- Department
- SC Nefrologia Dialisi Trapianto Renale
Research Overview
- Evaluation of XyloCore Efficacy and Safety Compared to Standard Glucose Solutions in Peritoneal Dialysis for End-Stage Kidney Disease Patients
- Efficacy and Safety of Finerenone in Non-Diabetic Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
- Efficacy and Safety Evaluation of Ravulizumab in Adults with Proliferative Lupus Nephritis or Immunoglobulin A Nephropathy: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 59 of 296 partner sites.
Specializations
Chronic Kidney Disease Management
This investigator specializes in treating various forms of chronic kidney disease (CKD), with particular emphasis on both diabetic and non-diabetic manifestations. Their research encompasses innovative therapeutic approaches for end-stage kidney disease and explores new treatment modalities including peritoneal dialysis solutions.
- End-stage renal disease management
- Peritoneal dialysis optimization
- Progressive CKD treatment
Glomerular Diseases
The investigator focuses on treating complex glomerular conditions, particularly Immunoglobulin A Nephropathy (IgAN) and Lupus Nephritis (LN). Their work involves evaluating novel therapeutic agents targeting these specific kidney disorders.
- IgA Nephropathy treatment
- Lupus Nephritis management
- Proteinuria reduction strategies
Cardiorenal Medicine
This clinical researcher specializes in the intersection of kidney disease and hypertension. Their expertise extends to investigating treatments that address both renal function and cardiovascular outcomes in CKD patients.
- Hypertension management in CKD
- Cardiovascular risk reduction
- Albuminuria treatment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.